Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

£0.5 Million DHT Boost for Humane Research

Published: Monday, October 29, 2012
Last Updated: Monday, October 29, 2012
Bookmark and Share
Call for applications for next wave of grant funding also announced.

The Dr Hadwen Trust (DHT) has announced grants totalling £577,687, funding innovative and humane research into Alzheimer’s disease, Parkinson’s disease, oesophageal cancer, brain tumours and toxicology.

The research projects will be undertaken at five universities in England and Scotland. Their collective aim is to further the understanding and treatment of life threatening diseases while simultaneously developing alternative methods to replace the use of animals in biomedical research.

The potential number of animals to be saved from invasive and painful procedures as a result of the success of these projects is immeasurable.

The new projects aim to:
• Improve understanding of the role of proteins in development and cell function that will lead to a better understanding and treatment of Alzheimer’s disease (Royal Holloway University)

• Develop the use of plant cells to emulate the development of Parkinson’s disease in human cells (Westminster University)

• Three dimensional cell model to allow the study of Barrett’s oesophagus and its progression to cancer (Dundee University)

• Generate human liver cells from pluripotent human stem cells to replace animals in toxicology (Edinburgh University)

• Utilize an effective 3D blood-brain barrier model to identify nanoparticle systems which may be effective drug carriers used to combat brain tumours and other neurological diseases (Portsmouth University)

Kailah Eglington, Chief Executive of the Dr Hadwen Trust, said: “We are delighted to announce funding for a further five ground-breaking, new research projects which promise to deliver benefits to both humans and animals. Each of these projects promises to significantly increase our understanding of devastating diseases whilst replacing animals used in scientific research.”

To find out more about the DHT research grants, please visit:

2012 Call for Grant Applications
The DHT is also making its annual call for applications for the next wave of grants:

Awarded in summer 2013, the deadline for preliminary applications is 17th December 2012.

Kailah Eglington, continues: “In making research grants available annually, we are urging all scientists to think about how they can help shape a more effective and humane future for medical research by using non-animal methods in their work.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Exploring the Causes of Cancer
Queen's research to understand the regulation of a cell surface protein involved in cancer.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
RNA-Based Drugs Give More Control Over Gene Editing
CRISPR/Cas9 gene editing technique can be transiently activated and inactivated using RNA-based drugs, giving researchers more precise control in correcting and inactivating genes.
University of Glasgow Researchers Make An Impact in 60 Seconds
Early-career researchers were invited to submit an engaging, dynamic and compelling 60 second video illuminating an aspect of their research.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
CRISPR-Cas9 Gene Editing: Check Three Times, Cut Once
Two new studies from UC Berkeley should give scientists who use CRISPR-Cas9 for genome engineering greater confidence that they won’t inadvertently edit the wrong DNA.
Genetically Engineering Algae to Kill Cancer Cells
New interdisciplinary research has revealed the frontline role tiny algae could play in the battle against cancer, through the innovative use of nanotechnology.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos